Melano, Raymond E.

HRN: 27-37-02  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/23/2025
06/30/2025
IV
500mg
Q6h
TETANUS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  BloodstreamCentral Nervous System    Compliance to guidelines: